Valneva Scotland Ltd. – FDA 483, Sep 9, 2022
An FDA inspection of Valneva Scotland Limited, a vaccine sterile bulk manufacturer in Livingston, Scotland, revealed significant deficiencies across multiple areas. The firm failed to maintain adequate quality control, including untimely deviation closures and insufficient investigations into particle contamination in JEV vaccine batches. Additionally, issues were noted in aseptic processing, laboratory controls, and employee training, indicating a broad lack of adherence to established procedures and good manufacturing practices.
ID · d2a1278b-7fae-4fea-973b-3e9920d25ad4
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.